NVS catalyst calendar
Clinical trials led by listed companies, by the completion date the sponsor registered on ClinicalTrials.gov, soonest first, from today. Most future dates are the sponsor's estimate and can move.
Windows longer than 90 days are part of TrialScanner, so this list covers the next 90 days.
November 2026
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Nov 25, 2026Sponsor estimate | NCT07928037A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic...Novartis Pharmaceuticals · Metastatic Castration-Resistant Prostate Cancer | NVSLead | No phase registered | Not yet recruiting | Locked | Locked | Locked |
- Primary completion Nov 25, 2026Sponsor estimateNo phase registeredNCT07928037A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic...Novartis Pharmaceuticals · Metastatic Castration-Resistant Prostate CancerNot yet recruitingNVSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
January 2027
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jan 1, 2027Sponsor estimate | NCT07945548A Study Characterizing the Elevated Liver Enzymes in Ribociclib Treated HR+ HER2- Advanced Breast Cancer Patients Using a Machine...Novartis Pharmaceuticals · Breast Cancer | NVSLead | No phase registered | Not yet recruiting | Locked | Locked | Locked |
| Jan 5, 2027Sponsor estimate | NCT07770074A Real-World Study of Second-line Therapies Among Radioiodine-refractory Differentiated Thyroid Cancer (RAI-R DTC) PatientsNovartis Pharmaceuticals · Radioiodine-refractory Differentiated Thyroid Cancer | NVSLead | No phase registered | Not yet recruiting | Locked | Locked | Locked |
| Jan 30, 2027Sponsor estimate | NCT07896746Factors Influencing Adoption of a Novel Malaria Treatment in Côte d'Ivoire, Ghana, and RwandaNovartis Pharmaceuticals · Malaria | NVSLead | No phase registered | Not yet recruiting | Locked | Locked | Locked |
- Primary completion Jan 1, 2027Sponsor estimateNo phase registeredNCT07945548A Study Characterizing the Elevated Liver Enzymes in Ribociclib Treated HR+ HER2- Advanced Breast Cancer Patients Using a Machine...Novartis Pharmaceuticals · Breast CancerNot yet recruitingNVSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 5, 2027Sponsor estimateNo phase registeredNCT07770074A Real-World Study of Second-line Therapies Among Radioiodine-refractory Differentiated Thyroid Cancer (RAI-R DTC) PatientsNovartis Pharmaceuticals · Radioiodine-refractory Differentiated Thyroid CancerNot yet recruitingNVSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 30, 2027Sponsor estimateNo phase registeredNCT07896746Factors Influencing Adoption of a Novel Malaria Treatment in Côte d'Ivoire, Ghana, and RwandaNovartis Pharmaceuticals · MalariaNot yet recruitingNVSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerHow to read this calendar
Completion dates as registered on ClinicalTrials.gov by the sponsor, for trials Signal8 links to a listed company. Most future dates are the sponsor's estimate and move. A completion date is when the last participant is measured, not when results are announced.
The window starts today. A date the sponsor registered to the day is listed when it falls inside the window; a date that has already passed is never listed as upcoming, even when the sponsor has not updated it yet. A date registered to the month only (shown as, say, Dec 2026) could be any day of that month, so it is listed only when the whole month falls inside the window. TrialScanner never adds a day the sponsor did not register.
By default the list shows trials where a listed company is the lead sponsor. Trials a listed company only collaborates on (as a partner, drug supplier or contract research organization) are added with the role filter, and every company is labelled Lead or Collaborator.
Free readers see the first 25 trials of any filter and windows up to 90 days, with the trial, phase, status, sponsor and primary completion. Enrollment, interventions, the start and completion dates, longer windows and later pages are part of the plan. See the methodology.